EMJ GOLD: Pharma news, views and analysis

For this week's GOLD nugget, Helena highlights not one but two of GOLD's previous guests from the world of Medical Affairs: Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson, and Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology, AstraZeneca. They explore the potential value that can come from collaborating with different industries and some tips for measuring the...

The GOLD Podcast may be on a break, but Helena is still here to provide you with some great insights – or GOLD Nuggets, if you will – from key opinion leaders in the pharmaceutical industry. In this special episode, she looks back at the very first episode of Season 2 which featured Judy Stewart, Senior Vice President and Head of US Vaccines at GSK. Helena considers some of the gold nuggets that J...

As Helena and Marc wrap up this season, they're joined by Mike Watson, Chief Executive Officer of Mevox – a company committed to bringing vaccine technology into the 21 st  century.   Mike discusses the importance of developing new measles, mumps and rubella (MMR) vaccines, Mevox's success so far in achieving this ambition – reaching series B funding – and its future trajectory, how COVID-19 will...

This week, Claire Gillis, CEO, VMLY&R Health joins Helena and Marc on the airwaves to discuss the health and pharma highlights from the recent Cannes Lions International Festival, including the power of technology, how to spend smart on campaigns and her top moment from the festival this year. If you're interested in learning more about the topic areas discussed in this episode, check out the foll...

In an interview double bill, Helena and Marc are joined two fantastic guests from the worlds of pharma marketing and commercial affairs. Michele Manto, Chief Commercial Officer, Galapagos, shares his thoughts on the differences in leading a large pharma company and an agile biotech, amongst other exciting topics, while Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk, talks...

In this episode, GOLD is joined by recent catalyst interviewee Claus Zieler, President of Established Markets, Astellas, who discusses  crisis management, the importance of leaders in shaping company culture, the innovation he is most excited about, and much more.   If you're interested in learning more about the topic areas discussed in this episode, check out the following content:   Claus Ziele...

In this week's episode, the GOLD team is joined by Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson. After first meeting Luca when he contributed to a GOLD article about the transition from medicine to medical affairs in 2021, we invited him to join us on the airwaves to delve further into his experience within the function, he discusses how the medical affairs function ha...

In this Men's Health Week special, the GOLD team is joined by Peter Baker, Director, Global Action on Men's Health and Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology. The two guests reveal what they think are the most pressing issues within men's health today, highlight the importance of awareness campaigns, and comment on the role pharma can play in encourag...

In this episode of the podcast, the GOLD team is joined by Eric Bouilloux, Chief Development Officer, Istesso. Helena and Eric discuss his impressive career within the pharmaceutical space, drill down into the potential of immunometabolism in diseases like multiple sclerosis, highlight some tips and tricks for progressing within a chosen career path and review his predictions from his first interv...

In this episode, the GOLD team is joined by Natalie Yeadon, Co-Founder and CEO, Impetus Digital, to delve deeper into our recent feature, 'Getting into gamification', Content and Editorial Assistant Jade Williams talks to Natalie about how pharma companies can best implement gamification into their practices and what internal and external benefits they can gain.   If you're interested in learning...

In this episode, GOLD speaks to Lenias Hwenda, Founder and CEO, Medicines for Africa, and Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Following on from GOLD's recent 'Pharma in South Africa' feature, Lenias explains what the implementation of South Africa's new healthcare system will mean for global pharma, as well as exploring genomics and m...

In this special bonus episode, GOLD's Editor Helena Beer reflects on the themes and her own key takeaways from this month's NEXT Pharma Summit. What challenges are facing pharma, and what does the industry need to do to overcome these? Assistant Editor Isabel O'Brien also catches up with the event's founder and chairman Dario Safaric to discuss his event highlights and thoughts on pharma's future....

In this episode, GOLD is joined by Emma Booth, Executive Director, Global Business Process and Insights Lead, R&D Strategy and Operations at Amgen. She discusses medical affairs communication and strategy, the power of data initiatives and the roadblocks that are preventing these from reaching their full potential, plus balancing leadership with nurturing one's own aspirations.   If you're interes...

In this episode,  GOLD  is joined by two of the pharmaceutical industry's most unwavering mental health advocates: Wendy Bartie, Senior Vice President, US Oncology, Bristol Myers Squibb, and Courtney Billington, President, Janssen Neuroscience. They discern what resources pharma companies should be making available to their employees, what the industry's role is in supporting patient mental health...

In this episode, Helena is joined by Klaus Legau, Senior Advisor, Social Sustainability at Leo Pharma. Klaus reveals the most important facets of a social sustainability strategy and where he believes the pharmaceutical industry is falling short in this respect, as well as offering expert advice to those starting out in policy campaigning.   If you're interested in learning more about the topic ar...

In this episode, GOLD speaks with Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology at AstraZeneca. She discusses all things medical affairs, delving into analytics, evidence generation, hiring candidates from non-traditional backgrounds and much more. Following on from GOLD's recent online poll, the team   also hears from some special guests about their take on using TikTok as a pharma...

In this episode, GOLD is joined by Aaron Grandy, Associate Director, Alira Health, and Co-Founder, Precision Healthcare Consulting, who discusses the aim of his start-up, GoMed, on access and health outcomes in Africa. Plus, Laurence Woollard, Founder and Director, On The Pulse Consultancy, joins the team to explore the haemophilia landscape and share key messages for the pharma industry. If you'r...

This week, Marc and Helena are back together in the studio once more, and to mark the midpoint of season two, GOLD's Assistant Editor, Isabel O'Brien, joins them to check in on our guests' predictions for 2022. Hear from Julie Ross, Kay Wesley and Jennifer Cain Birkmose as the team pours over their predictions to see if clinical trials have been drastically decentralised, whether hybrid events are...

In this episode,  GOLD  is joined by Davidek Herron, Global Head of Digital, Roche, who discusses his journey from professional basketball player to pharma leader, including the lessons he has taken from sport into business. He also shares his unique take on digital transformation and the secret to job satisfaction.   If you're interested in learning more about the topic areas discussed in this ep...

In this episode,  GOLD  is joined by Magnus Björsne, CEO, AstraZeneca BioVentureHub, who discusses the impact of the pandemic on innovation, collaboration and creativity within the industry. This episode also features a special diabetes-focused 'Things you might have missed', with news on novel management and monitoring technology for people living with diabetes. If you're interested in learning m...

In this episode, GOLD is joined by Isabel Afonso, General Manager, Novartis Oncology China, who shares insights on the pharmaceutical landscape of the country and the potential of partnerships with multinational corporations, followed by a conversation with Dr Farid Khan, CEO and Founder, PharmaKure, about the vital ongoing need for drug development and the scientific details behind biopharmaceuti...

In this bonus episode, GOLD brings you the full feature-length interview with Claire Skentelbery, Director General, EuropaBio. She explores the contribution that biotech will have on Europe's future and economic footprint, the preparedness of Europe to deliver biotech's innovative therapies at scale, as well as the investment landscape for biotech-related SMEs.    If you're interested in learning...

In this episode, we speak to Claire Skentelbery, Director General, EuropaBio, about the biotech revolution, including how biotech companies could contribute to the European economy in the future and the readiness of Europe to deliver these innovative solutions at scale. The GOLD team also discusses the biotech revolution from an investor's perspective, exploring the risks and rewards of investing...

In this episode, Dr Nigel Guest, CEO, Trifolium Consulting, speaks to GOLD about his experiences as a GP during the pandemic, interactions with the pharma field force and his thoughts on the future of preventative medicines. Helena and Isabel additionally discuss the importance of making disease awareness campaigns really matter. If you're interested in learning more about the topic areas discusse...

In this special bumper episode to mark International Women's Day, Helena is joined by Nikki Jones, Head of Diversity, Equity and Inclusion at the Healthcare Businesswomen's Association, to discuss the role of this global celebration within the health space. The team also speaks to Aliya Omer, Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma, about how she navigated g...